Growth Metrics

Avai Bio (AVAI) Return on Equity (2018 - 2025)

Avai Bio's Return on Equity history spans 7 years, with the latest figure at 0.04% for Q1 2024.

  • On a quarterly basis, Return on Equity rose 3.0% to 0.04% in Q1 2024 year-over-year; TTM through Mar 2024 was 0.04%, a 3.0% increase, with the full-year FY2024 number at 0.02%, changed 0.0% from a year prior.
  • Return on Equity hit 0.04% in Q1 2024 for Avai Bio, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Equity for AVAI hit a ceiling of 0.04% in Q1 2024 and a floor of 0.03% in Q4 2020.
  • Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2020.
  • Biggest five-year swings in Return on Equity: decreased -4bps in 2020 and later grew 3bps in 2023.
  • Tracing AVAI's Return on Equity over 5 years: stood at 0.03% in 2020, then soared by 62bps to 0.01% in 2021, then skyrocketed by 63bps to 0.0% in 2022, then soared by 619bps to 0.02% in 2023, then soared by 66bps to 0.04% in 2024.
  • Business Quant data shows Return on Equity for AVAI at 0.04% in Q1 2024, 0.02% in Q4 2023, and 0.02% in Q3 2023.